Dymon Asia Capital (Singapore)’s Summit Healthcare Acquisition Corp. Warrant SMIHW Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio SMIHW Stock Details SMIHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-149,900	Closed	-$42.4K	–	155
2022 Q4	$42.4K	Sell	149,900 -100	-0.1%	-$22	0.01%	96
2022 Q3	$23K	Hold	150,000	–	–	0.01%	100
2022 Q2	$14K	Hold	150,000	–	–	﹤0.01%	115
2022 Q1	$30K	Buy	+150,000	New	+$72K	﹤0.01%	125

Dymon Asia Capital (Singapore)'s SMIHW Position: Q1 2023 in Review

Dymon Asia Capital (Singapore) sold out of Summit Healthcare Acquisition Corp. Warrant (SMIHW) in Q1 2023, closing a stake of 149,900 shares — an estimated $42.4K sold.

Dymon Asia Capital (Singapore) first reported a position in SMIHW in Q1 2022 and held it in 4 quarters. The position peaked at $42.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold SMIHW as of Q1 2023.

Dymon Asia Capital (Singapore) reported no remaining Summit Healthcare Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Dymon Asia Capital (Singapore) sold 149,900 Summit Healthcare Acquisition Corp. Warrant shares in Q1 2023, an estimated $42.4K.
Dymon Asia Capital (Singapore) first reported a position in Summit Healthcare Acquisition Corp. Warrant in Q1 2022 and held it in 4 quarters.
Dymon Asia Capital (Singapore)'s Summit Healthcare Acquisition Corp. Warrant position peaked at $42.4K in Q4 2022.
0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Warrant as of Q1 2023.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q1 2023, filed 12 May 2023.